Alps Advisors Inc Bio Rad Laboratories, Inc. Transaction History

Alps Advisors Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$463.67 - $597.16 $3,245 - $4,180	-7 Reduced 1.1%	630 $312,000
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $91,799 - $128,698	175 Added 37.88%	637 $359,000
Q4 2021 Feb 09, 2022	BUY	$708.84 - $794.68 $7,088 - $7,946	10 Added 2.21%	462 $349,000
Q3 2021 Nov 15, 2021	SELL	$657.71 - $825.77 $99,971 - $125,517	-152 Reduced 25.17%	452 $337,000
Q1 2021 May 07, 2021	BUY	$547.01 - $662.35 $51,965 - $62,923	95 Added 18.66%	604 $345,000
Q4 2020 Feb 03, 2021	SELL	$510.68 - $643.45 $5,106 - $6,434	-10 Reduced 1.93%	509 $297,000
Q3 2020 Nov 04, 2020	SELL	$454.43 - $535.6 $18,177 - $21,424	-40 Reduced 7.16%	519 $268,000
Q2 2020 Aug 05, 2020	SELL	$334.87 - $493.06 $20,092 - $29,583	-60 Reduced 9.69%	559 $252,000
Q1 2020 May 06, 2020	SELL	$320.01 - $409.07 $133,444 - $170,582	-417 Reduced 40.25%	619 $217,000
Q4 2019 Feb 07, 2020	SELL	$319.73 - $374.2 $14,387 - $16,839	-45 Reduced 4.16%	1,036 $383,000
Q3 2019 Nov 04, 2019	BUY	$304.55 - $345.24 $329,218 - $373,204	1,081 New	1,081 $360,000

459

19.6M

23.2K

37.4K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.1B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.